385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ibuprofen 5% gel (A A H Pharmaceuticals Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% gel (Thornton & Ross Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% gel (Unichem Plc) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nurofen 5% gel (Crookes Healthcare Ltd) 35 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibugel 5% gel (Dermal Laboratories Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid 5% gel (Goldshield Healthcare Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid 5% gel (Goldshield Healthcare Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid 5% gel (Goldshield Healthcare Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Radian B Ibuprofen 5% gel (William Ransom & Son Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibutop Ralgex Ibuprofen 5% gel (SSL International Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibutop Cuprofen Ibuprofen 5% gel (SSL International Plc) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibutop Cuprofen Ibuprofen 5% gel (SSL International Plc) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zacin 0.025% cream (Medeus Pharma) 45 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Axsain 0.075% cream (Medeus Pharma) 45 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eurax Hydrocortisone cream (Novartis Consumer Health UK Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eurax Hc cream (Thornton & Ross Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nurofen Maximum Strength 10% gel (Crookes Healthcare Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibugel Forte 10% gel (Dermal Laboratories Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid Forte 10% gel (Goldshield Healthcare Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid Forte 10% gel (Goldshield Healthcare Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Phor Pain Forte 10% gel (Goldshield Healthcare Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve Maximum Strength 10% gel (Diomed Developments Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve Maximum Strength 10% gel (Diomed Developments Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve 5% gel (Diomed Developments Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve 5% gel (Diomed Developments Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuleve Sports 5% gel (Dendron Brands Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lamisil 1% cream (Haleon UK Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lamisil 1% cream (Haleon UK Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lamisil AT 1% cream (Haleon UK Ltd) 7.5 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Acticin 0.025% cream (Strakan Ltd) 45 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Retin-A 0.025% cream (Janssen-Cilag Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fucidin 2% gel (LEO Pharma) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fucidin 2% gel (LEO Pharma) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Efudix 5% cream (Viatris UK Healthcare Ltd) 20 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Quinoderm cream (Ferndale Pharmaceuticals Ltd) 25 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Quinoderm cream (Ferndale Pharmaceuticals Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Isotrex 0.05% gel (Stiefel Laboratories Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzamycin gel (Schwarz Pharma Ltd) 23.3 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzamycin gel (Schwarz Pharma Ltd) 46.6 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Brevoxyl 4% cream (Haleon UK Ltd) 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
PanOxyl 5 cream (Haleon UK Ltd) 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
PanOxyl 2.5 Aquagel (Haleon UK Ltd) 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
PanOxyl 5 Aquagel (Haleon UK Ltd) 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Acnecide 5% gel (Galderma (UK) Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Panoxyl Acnegel 5 (Stiefel Laboratories Ltd) 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Curatoderm 4micrograms/g ointment (Crookes Healthcare Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Curatoderm 4micrograms/g ointment (Crookes Healthcare Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Curatoderm 4micrograms/g ointment (Crookes Healthcare Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Feldene 0.5% gel (Pfizer Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Feldene 0.5% gel (Pfizer Ltd) 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Feldene P 0.5% gel (Pfizer Consumer Healthcare) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Kent Pharma (UK) Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Kent Pharma (UK) Ltd) 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Unichem Plc) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Unichem Plc) 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous calamine cream (A A H Pharmaceuticals Ltd) 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous calamine cream (Thornton & Ross Ltd) 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous calamine cream (Unichem Plc) 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selsun 2.5% suspension (Chattem) 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selsun 2.5% suspension (Chattem) 150 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selsun 2.5% suspension (Chattem) 50 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nerisone 0.1% oily cream (Meadow Laboratories) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conotrane cream (Evolan Pharma AB) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Conotrane cream (Evolan Pharma AB) 500 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Algesal cream (Zeroderma Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Odour Free Lloyds cream (Thornton & Ross Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Econacort cream (Bristol-Myers Squibb Pharmaceuticals Limited) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ecostatin 1% cream (Bristol-Myers Squibb Pharmaceuticals Limited) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ecostatin 1% cream (Bristol-Myers Squibb Pharmaceuticals Limited) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Pevaryl 1% cream (Karo Pharma) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Gyno-Pevaryl 1% cream (Karo Pharma) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Gyno-Pevaryl 1% cream (Karo Pharma) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vioform-Hydrocortisone ointment (Novartis Consumer Health UK Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Vioform-Hydrocortisone cream (Novartis Consumer Health UK Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betnovate-C ointment (GlaxoSmithKline) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betnovate-C cream (GlaxoSmithKline) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dalacin 2% cream (Pfizer Ltd) 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Neutrogena T/Gel Therapeutic shampoo (Johnson & Johnson Ltd) 125 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Neutrogena T/Gel Therapeutic shampoo (Johnson & Johnson Ltd) 250 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clinitar 2% shampoo (Cambridge Healthcare supplies Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Isotrexin gel (Stiefel Laboratories Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alphosyl 2 in 1 shampoo (GlaxoSmithKline Consumer Healthcare) 125 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alphosyl 2 in 1 shampoo (GlaxoSmithKline Consumer Healthcare) 250 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alphosyl cream (Haleon UK Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eurax 10% cream (Thornton & Ross Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eurax 10% cream (Thornton & Ross Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Locoid C cream (Yamanouchi Pharmaceuticals) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (A A H Pharmaceuticals Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Kent Pharma (UK) Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Powergel 2.5% gel (A Menarini Pharmaceuticals UK Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Powergel 2.5% gel (A Menarini Pharmaceuticals UK Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tiloket 2.5% gel (Tillomed Laboratories) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Unichem Plc) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nizoral 2% cream (Janssen-Cilag Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Daktarin Gold 2% cream (McNeil Ltd) 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoconazole 2% shampoo (A A H Pharmaceuticals Ltd) 120 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoconazole 2% shampoo (Alpharma Limited) 120 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nizoral 2% shampoo (Thornton & Ross Ltd) 120 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 29 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module